ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device

Tuesday, April 3, 2018

Submitted by

Claire Vernon

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2017.08.057

Author(s)

Igor Gosev, Michael S. Kiernan, Peter Eckman, Behzad Soleimani, Ahmet Kilic, Nir Uriel, Johnatan D. Rich, Jason N. Katz, Jennifer Cowger, Brian Lima, Siobhan McGurk, Meredith A. Brisco-Bacik, Sanjin Lee, Susan M. Joseph, Chetan B. Patel, for the Evolving Mechanical Support Research Group (EMERG) Investigators

Gosev and colleagues evaluated the baseline characteristics and outcomes in 156 patients from 12 centers who survived at least four years on left ventricular assist device (LVAD) support. Among this group of patients, mean survival was 7.1 years (95% CI 6.7 to 7.5 years). The average readmission rate was 1.1 ± 0.9 per patient-year, and the authors suggest that this low rate of complications could be responsible for the long survival seen in these patients.